Limoneria cuts down debt with sale of Tulare property for $100M
The future of Santa Paula-based Limoneira came into sharper focus on Feb. 1 when the company sold a major agribusiness holding in the Tulare area for $100 million, recouping $99 million in cash while also reaching an agreement to grow, pack and market lemons produced on the property. PGIM Agricultural Investments, a unit of PGIM Read More →
Community Memorial rebrands to signal a new era
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Housing projects in Ventura are well-funded but need to happen quicker
The Housing Trust Fund of Ventura County has made impressive progress over the last year in its move to develop affordable housing units throughout the county. At its annual meeting on Jan. 18, HTFVC described the steps they’ve taken to ensure future housing projects as well as the state of current projects. Alexander Russell, HTFVC’s Read More →
Region’s unemployment rate dips back below 3%
The unemployment rate across all three counties along the Central Coast dipped in the month of December, according to data released on Jan. 20 by the California Employment Development Department. Combined, the tri-county area had an unemployment rate of 2.9% in the month of December, down from 3.2% in the month of November. It is Read More →
Community Memorial Health adds CEO, Chief of Staff
Mick Zdeblick officially stepped into his new role as the CEO of Community Memorial Health on Jan. 9, replacing Gary Wilde, who retired after helming the position since 2004. Community Memorial Health, which offers a network of services throughout Ventura County, welcomes Zdeblick from Medford, Oregon, where he served as the CEO of Asante Rogue Read More →
Capsida announces multi-year agreement with Eli Lilly subsidiary
Thousand Oaks-based Capsida Therapeutics has entered into a multi-year agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, to develop transformative genetic medicines for serious diseases, Capisda announced Jan. 4. As per the agreement, Capsida will receive $55 million in the form of an upfront payment and a commitment to participate Read More →
